^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

minocycline

Associations
Company:
Generic mfg.
Drug class:
Immunomodulator, Protein synthesis inhibitor, IL-1α inhibitor, IL-6 modulator
Related drugs:
Associations
4d
Stony Brook Medicine Anti-Inflammatory Trial (clinicaltrials.gov)
P4, N=42, Not yet recruiting, Stony Brook University
New P4 trial
|
celecoxib oral • minocycline
7d
Mino-PK: Pharmacokinetic Study of Minocycline in Patients With Pulmonary Nontuberculous Mycobacterial Disease (clinicaltrials.gov)
P2, N=15, Recruiting, Radboud University Medical Center | Trial completion date: Sep 2024 --> Dec 2025 | Trial primary completion date: Aug 2024 --> Aug 2025
Trial completion date • Trial primary completion date • Nontuberculous mycobacteria
|
minocycline
7d
New P1 trial
|
CD8 (cluster of differentiation 8) • IFNG (Interferon, gamma) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • CD4 (CD4 Molecule) • IL10 (Interleukin 10) • IFNA1 (Interferon Alpha 1) • CRP (C-reactive protein)
|
minocycline
9d
PINK1-deficiency facilitates mitochondrial iron accumulation and colon tumorigenesis. (PubMed, Autophagy)
Clinically used drugs deferiprone and minocycline reduced mitochondrial iron and superoxide levels, resulting in decreased colon tumor cell growth in vitro and in vivo. Manipulating the mitochondrial iron uptake protein MCU (mitochondrial calcium uniporter) also affected cell and xenograft tumor growth. This study suggests that therapies aimed at reducing mitochondrial iron levels may effectively inhibit colon tumor growth, particularly in patients with low PINK1 expression.
Journal
|
PTEN (Phosphatase and tensin homolog) • IL1B (Interleukin 1, beta) • NLRP3 (NLR Family Pyrin Domain Containing 3) • PINK1 (PTEN Induced Kinase 1)
|
minocycline
10d
CXCL1-CXCR2 signaling mediates the activation of microglia in the nucleus tractus solitarii to promote pancreatic cancer-induced pain. (PubMed, Brain Behav Immun)
In mice with pancreatic cancer-induced pain, the microglia activation in the NTS was observed, characterized by increased cell density and decreased process number and length, while injection of microglia inhibitor minocycline in the NTS alleviated pancreatic cancer-induced pain...Blocking CXCL1-CXCR2 signaling by injection of CXCL1 neutralizing antibody or CXCR2 antagonist SB225002 in the NTS of mice with pancreatic cancer-induced pain alleviated abdominal hypersensitivity and hunching behavior, and also reversed the activation of neurons and microglia. Additionally, injection of recombinant CXCL1 in the NTS of sham-operated mice induced abdominal pain, and activated the neurons and microglia. In summary, our study highlights the critical role of NTS microglia activation mediated by CXCL1-CXCR2 signaling in pancreatic cancer-induced pain.
Journal
|
CXCR2 (Chemokine (C-X-C motif) receptor 2) • CXCL1 (Chemokine (C-X-C motif) ligand 1)
|
SB225002 • minocycline
15d
A multicenter, randomized, double-blind, placebo-controlled clinical study of bifidobacterium quadruple viable tablets assisted P-CAB quadruple therapy for refractory Helicobacter pylori infection (ChiCTR2400090233)
P4, N=574, Not yet recruiting, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Tongji Hospital, Tongji Medical College, Huazhong University o
New P4 trial
|
minocycline
15d
New P4 trial
|
minocycline
28d
Impact of ciprofloxacin with autophagy on renal tubular injury. (PubMed, Medicine (Baltimore))
This indicates that ciprofloxacin enhances autophagy, increasing the amount of free Beclin-1 via phosphorylated Bcl-2, and inhibits caspase activity. Therefore, ciprofloxacin might protect against renal tubular injury through the activation of autophagy in the setting of acute kidney injury.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • CASP3 (Caspase 3) • BECN1 (Beclin 1)
|
minocycline
28d
Enrollment change • Adverse events • Metastases
|
EGFR (Epidermal growth factor receptor)
|
EGFR L858R • EGFR exon 19 deletion
|
Rybrevant (amivantamab-vmjw) • Lazcluze (lazertinib) • minocycline
2ms
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response (clinicaltrials.gov)
P3, N=400, Recruiting, University of Nebraska | Trial primary completion date: Mar 2026 --> Mar 2027
Trial primary completion date
|
CRP (C-reactive protein)
|
Rituxan (rituximab) • hydroxychloroquine • tofacitinib • Kevzara (sarilumab) • leflunomide • minocycline
2ms
New P1 trial
|
minocycline
3ms
Central innate immunization induces tolerance against post-traumatic stress disorder-like behavior and neuroinflammatory responses in male mice. (PubMed, Brain Behav Immun)
Inhibition of microglia by pretreatment with minocycline or depletion of microglia by PLX3397 abolished the preventive effect of low-dose LPS pre-injection on mSPS-induced anxiety- and fear-like behavior and neuroinflammatory responses. These results suggest that pre-stimulation of microglia may prevent the development of PTSD-like behaviors by attenuating the development of neuroinflammatory responses. This could help to develop new strategies to prevent the damaging effects of harmful stress on the brain.
Preclinical • Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL1B (Interleukin 1, beta)
|
Turalio (pexidartinib) • minocycline
3ms
Risk Factor Analysis for Anti-epidermal Growth Factor Receptor Monoclonal Antibody-induced Problematic Skin Toxicities in Patients With Liver Metastatic Colorectal Cancer. (PubMed, In Vivo)
Age <65 years and anemia were identified as independent baseline risk factors. Additionally, combination prophylaxis was found to be a preventive factor against anti-EGFR monoclonal antibody-induced grade ≥2 overall skin toxicities in patients with liver metastatic CRC.
Retrospective data • Journal • Metastases
|
EGFR (Epidermal growth factor receptor)
|
Erbitux (cetuximab) • Vectibix (panitumumab) • minocycline
3ms
New P4 trial
|
minocycline
3ms
Optimization of Minocycline for Helicobacter Pylori Rescue Treatment (clinicaltrials.gov)
P4, N=476, Recruiting, Shanghai Jiao Tong University School of Medicine
New P4 trial
|
minocycline
3ms
Effect of minocycline on changes in affective behaviors, cognitive function, and inflammation in breast cancer survivors undergoing chemotherapy: a pilot randomized controlled trial. (PubMed, Breast Cancer Res Treat)
Despite attenuation of IL-8, minocycline did not alter self-reported affective symptoms or cognition in this cohort of BC survivors undergoing chemotherapy. The effect of minocycline on BC survivors symptomatic for depression before chemotherapy warrants further investigation.
Journal
|
CXCL8 (Chemokine (C-X-C motif) ligand 8)
|
minocycline
3ms
Intra-Arterial Neuroprotective Agents and Cold Saline in Ischemic Stroke Intervention (clinicaltrials.gov)
P1, N=24, Recruiting, Northwell Health | Trial completion date: Jun 2024 --> Sep 2025 | Trial primary completion date: Jun 2024 --> Sep 2024
Trial completion date • Trial primary completion date
|
minocycline
4ms
New trial
|
minocycline
4ms
New P4 trial
|
minocycline
4ms
Microglia contribute to nociception via CSF-1R signaling pathway in rat orofacial carcinoma. (PubMed, Oral Dis)
The results of our study showed that blocking microglial activation via CSF1R may help prevent cancer-induced orofacial pain.
Preclinical • Journal
|
CSF1R (Colony stimulating factor 1 receptor)
|
Turalio (pexidartinib) • minocycline
4ms
Antihypertensive Mechanisms of Minocycline in Resistant Hypertension (clinicaltrials.gov)
P4, N=120, Not yet recruiting, University of Florida | Initiation date: Apr 2024 --> Oct 2024
Trial initiation date
|
minocycline
4ms
APT-TBI-01: Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury (clinicaltrials.gov)
P2, N=672, Enrolling by invitation, University of California, San Francisco | Not yet recruiting --> Enrolling by invitation
Enrollment open
|
GFAP (Glial Fibrillary Acidic Protein)
|
atorvastatin • minocycline
4ms
Sepsis-induced inflammatory demyelination in medullary visceral zone and cholinergic anti-inflammatory pathway: Insights from a Rat's model study. (PubMed, Heliyon)
The second experiment involved in 56 rats, through central anti-inflammation by feeding with 10 mg/ml minocycline sucrose solution as the only water source, or right vagus transection excepting for central anti-inflammation as a mean of the CAP's functional cancel, we confirmed that the neuroinflammation in MVZ affected systemic inflammation through CAP in sepsis...However, right vagotomy abolished the central anti-inflammatory effect. Our study uncovered that MVZ's neuroinflammation may play a crucial role in the uncontrolled systemic inflammation through inflammatory demyelination in MVZ, which disrupts CAP's modulation on the systemic inflammation in early sepsis.
Preclinical • Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • FAP (Fibroblast activation protein, alpha) • MMP9 (Matrix metallopeptidase 9) • GFAP (Glial Fibrillary Acidic Protein) • OLIG2 (Oligodendrocyte Transcription Factor 2)
|
minocycline
5ms
Pathological polarizations from microglia to astrocyte contributes to spatial memory deficit in methamphetamine abstinence mice. (PubMed, Cereb Cortex)
Locally suppressing dCA1 M1-like microglia activation with minocycline administration attenuated A1-like polarization of astrocytes, ameliorated dCA1 neurotoxicity, and, most importantly, rescued spatial memory in methamphetamine abstinence mice. The effective time window of minocycline treatment on spatial memory is the methamphetamine exposure period, rather than the long-term methamphetamine abstinence.
Preclinical • Journal
|
TNFA (Tumor Necrosis Factor-Alpha)
|
minocycline
6ms
Minocycline for Helicobacter Pylori Rescue Treatment (clinicaltrials.gov)
P=N/A, N=823, Completed, Shanghai Jiao Tong University School of Medicine | Recruiting --> Completed | N=600 --> 823 | Trial completion date: Jun 2034 --> Apr 2024 | Initiation date: Oct 2021 --> Mar 2021
Trial completion • Enrollment change • Trial completion date • Trial initiation date • HEOR • Real-world evidence • Real-world
|
minocycline
6ms
APT-TBI-01: Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury (clinicaltrials.gov)
P2, N=672, Not yet recruiting, University of California, San Francisco | Trial completion date: Feb 2029 --> Aug 2029 | Trial primary completion date: Feb 2028 --> Aug 2028
Trial completion date • Trial primary completion date
|
GFAP (Glial Fibrillary Acidic Protein)
|
atorvastatin • minocycline
7ms
Effects of AMP Application After Non-surgical Periodontal Therapy on Treatment of Periodontitis (clinicaltrials.gov)
P4, N=51, Completed, Beijing Stomatological Hospital, Capital Medical University | Not yet recruiting --> Completed
Trial completion
|
minocycline
7ms
Enrollment change • Adverse events • Metastases
|
EGFR (Epidermal growth factor receptor)
|
EGFR L858R • EGFR exon 19 deletion
|
Rybrevant (amivantamab-vmjw) • Lazcluze (lazertinib) • minocycline
8ms
Minocycline induced apoptosis and suppressed expression of matrix metalloproteinases 2 and 9 in the breast cancer MCF-7 cells. (PubMed, Mol Biol Rep)
These findings further confirmed the anticancer effect of minocycline and highlighted that minocycline maybe considered as potential therapeutic agent for breast cancer treatment.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • MMP2 (Matrix metallopeptidase 2) • BAX (BCL2-associated X protein) • CASP3 (Caspase 3) • MMP9 (Matrix metallopeptidase 9) • ANXA5 (Annexin A5)
|
BCL2 expression
|
minocycline
8ms
Minocycline for Helicobacter Pylori Rescue Treatment (clinicaltrials.gov)
P=N/A, N=600, Recruiting, Shanghai Jiao Tong University School of Medicine
New trial • HEOR • Real-world evidence • Real-world
|
minocycline
9ms
Spinal microglial M1 polarization contributes paclitaxel-induced neuropathic pain by triggering cells necroptosis. (PubMed, J Biochem Mol Toxicol)
The effect of microglial polarization on the regulation of spinal necroptosis was elucidated by administering minocycline to inhibit PTX-induced M1 polarization of spinal microglia caused by PTX. Overall, this study suggests that PTX-induced polarization of spinal microglia leads to RIP3/MLKL-regulated necroptosis, resulting in PIPN. These findings suggest a potential target for the prevention and treatment of neuropathic pain.
Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • RIPK3 (Receptor Interacting Serine/Threonine Kinase 3) • MLKL (Mixed Lineage Kinase Domain Like Pseudokinase)
|
paclitaxel • minocycline
9ms
Enrollment open
|
EGFR (Epidermal growth factor receptor)
|
EGFR L858R • EGFR exon 19 deletion
|
Rybrevant (amivantamab-vmjw) • Lazcluze (lazertinib) • minocycline
9ms
Study 2: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients (clinicaltrials.gov)
P1/2, N=0, Withdrawn, University of Florida | N=56 --> 0 | Not yet recruiting --> Withdrawn
Enrollment change • Trial withdrawal
|
minocycline
9ms
New P4 trial
|
minocycline
9ms
New P2/3 trial
|
minocycline
10ms
Trial completion
|
minocycline
10ms
Minocyclin in Ulcerative Colitis as Added on Therapy (clinicaltrials.gov)
P2, N=46, Recruiting, Mostafa Bahaa | Not yet recruiting --> Recruiting
Enrollment open
|
minocycline
10ms
Microglia Promote Inhibitory Synapse Phagocytosis in the Spinal Cord Dorsal Horn and Modulate Pain-Like Behaviors in a Murine Cancer-Induced Bone Pain Model. (PubMed, Anesth Analg)
Microglia-mediated GABAergic synapse pruning in the spinal cord dorsal horn in bone cancer pain mice, which might be associated with the declined CD47-SIRPα signal. Our research uncovered an innovative mechanism that highlighted microglia-mediated synaptic phagocytosis in a murine cancer-induced bone pain model.
Preclinical • Journal
|
CD47 (CD47 Molecule) • SIRPA (Signal Regulatory Protein Alpha)
|
minocycline
10ms
Effect of Minocycline on Inflammation in Depressed Patients (clinicaltrials.gov)
P2, N=60, Recruiting, IRCCS Centro San Giovanni di Dio Fatebenefratelli
New P2 trial
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL17A (Interleukin 17A) • CRP (C-reactive protein)
|
minocycline
11ms
New P2 trial
|
minocycline
11ms
Application of metronidazole combined with minocycline in reducing infection after dental implant in patients with localized periodontitis (PubMed, Shanghai Kou Qiang Yi Xue)
The administration of minocycline hydrochloride and metronidazole in patients with localized periodontitis undergoing implantation can reduce oral inflammatory response, reduce postoperative infection and other complications, and improve periodontal health.
Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • CRP (C-reactive protein)
|
minocycline